152 related articles for article (PubMed ID: 15220705)
1. The epidemiology, treatment patterns, and costs of cytomegalovirus retinitis in the post-haart era among a national managed-care population.
Mahadevia PJ; Gebo KA; Pettit K; Dunn JP; Covington MT
J Acquir Immune Defic Syndr; 2004 Aug; 36(4):972-7. PubMed ID: 15220705
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Kedhar SR; Jabs DA
Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
[TBL] [Abstract][Full Text] [Related]
3. Cost-utility analysis of prophylactic treatment with oral ganciclovir for cytomegalovirus retinitis.
Moore RD; Chaisson RE
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Sep; 16(1):15-21. PubMed ID: 9377120
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
5. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Sugar EA; Jabs DA; Ahuja A; Thorne JE; Danis RP; Meinert CL;
Am J Ophthalmol; 2012 Jun; 153(6):1016-24.e5. PubMed ID: 22310076
[TBL] [Abstract][Full Text] [Related]
6. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
Arevalo JF; Garcia RA; Mendoza AJ
Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment.
Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD;
Ophthalmology; 2007 Apr; 114(4):780-6. PubMed ID: 17258320
[TBL] [Abstract][Full Text] [Related]
8. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Whitcup SM
JAMA; 2000 Feb; 283(5):653-7. PubMed ID: 10665706
[TBL] [Abstract][Full Text] [Related]
10. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy.
Deayton JR; Wilson P; Sabin CA; Davey CC; Johnson MA; Emery VC; Griffiths PD
AIDS; 2000 Jun; 14(9):1163-70. PubMed ID: 10894280
[TBL] [Abstract][Full Text] [Related]
11. Incremental cost-effectiveness analysis of intravenous ganciclovir versus oral ganciclovir in the maintenance treatment of newly diagnosed cytomegalovirus retinitis in patients with AIDS.
Rachlis A; Smaill F; Walker V; Hotchkies L; Jones A
Pharmacoeconomics; 1999 Jul; 16(1):71-84. PubMed ID: 10539123
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal ganciclovir maintenance injection for cytomegalovirus retinitis: efficacy of a low-volume, intermediate-dose regimen.
Teoh SC; Ou X; Lim TH
Ophthalmology; 2012 Mar; 119(3):588-95. PubMed ID: 22137552
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Jabs DA; Van Natta ML; Kempen JH; Reed Pavan P; Lim JI; Murphy RL; Hubbard LD
Am J Ophthalmol; 2002 Jan; 133(1):48-61. PubMed ID: 11755839
[TBL] [Abstract][Full Text] [Related]
14. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
Jouan M; Savès M; Tubiana R; Carcelain G; Cassoux N; Aubron-Olivier C; Fillet AM; Nciri M; Sénéchal B; Chêne G; Tural C; Lasry S; Autran B; Katlama C;
AIDS; 2001 Jan; 15(1):23-31. PubMed ID: 11192865
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.
Lin DY; Warren JF; Lazzeroni LC; Wolitz RA; Mansour SE
Retina; 2002 Jun; 22(3):268-77. PubMed ID: 12055458
[TBL] [Abstract][Full Text] [Related]
16. Incidence Rate and Risk Factors for Contralateral Eye Involvement among Patients with AIDS and Cytomegalovirus Retinitis Treated with Local Therapy.
Sittivarakul W; Benjhawaleemas T; Aui-Aree N; Jirarattanasopa P; Liabsuetrakul T
Ocul Immunol Inflamm; 2016 Oct; 24(5):530-6. PubMed ID: 26327465
[TBL] [Abstract][Full Text] [Related]
17. Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001.
Yust I; Fox Z; Burke M; Johnson A; Turner D; Mocroft A; Katlama C; Ledergerber B; Reiss P; Kirk O;
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):550-9. PubMed ID: 15232720
[TBL] [Abstract][Full Text] [Related]
18. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA
JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789
[TBL] [Abstract][Full Text] [Related]
19. HIV-associated retinopathy in the HAART era.
Goldberg DE; Smithen LM; Angelilli A; Freeman WR
Retina; 2005; 25(5):633-49; quiz 682-3. PubMed ID: 16077362
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy.
Doan S; Cochereau I; Guvenisik N; Diraison MC; Mousalatti H; Thanh HX
Am J Ophthalmol; 1999 Aug; 128(2):250-1. PubMed ID: 10458193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
